|Bid price||4,318.50||Open price||4,450.00|
|Ask price||4,321.00||Prev close||4,318.50|
Register now for FREE live AstraZeneca share prices, AstraZeneca stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get AstraZeneca Level 2 Data, indepth research tools and investor commentary for AstraZeneca (AZN) and other London Stock Exchange equities.
Register now for FREE AstraZeneca share price charts
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB0009895292|
|Activites||One of the world's leading pharmaceutical companies.||Index||FTSE 100|
|Latest Share Price (p)||4,318.50||Net Gearing (%)||58.84|
|Market Capitalisation (£m)||56,536.78||Gross Gearing (%)||69.22|
|Shares in issue (m)||1,265.23||Debt Ratio||59.10|
|P/E Ratio||20.04||Debt-to-Equity Ratio||0.64|
|Total dividends per share (p)||188.50||Assets / Equity Ratio||3.25|
|Dividend Yield (%)||4.47||Price to book value||3.05|
|Dividend cover (x)||2.79||ROCE (%)||6.78|
|Earning per share (p)||223.00||EPS Growth (%)||127.55|
|52 week high / low||5,505.00 / 3,680.00||DPS Growth (%)||5.84|
|Dec.Date||Type||Director||Pos||No. of Shares|
AstraZeneca has issued an update on its immuno-oncology late-stage clinical development programme in first-line non-small cell lung cancer, including a refinement of the Phase III MYSTIC trial. The MYSTIC trial was initially designed to assess the benefit of durvalumab monotherapy and...
Story provided by StockMarketWire.com
RNS Number : 3289U AstraZeneca PLC 17 January 2017 17 January 2017 07:00 ASTRAZENECA EXPANDS 1ST-LINE LUNG CANCER IMMUNO-ONCOLOGY PROGRAMME OPPORTUNITIES Refined endpoints and statistical analysis plan in the Phase III MYSTIC trial China...
Register now for FREE AstraZeneca company news
Got a good line of products, but the share price seem to go down , could it be due to the weak us dollar.
(option stock price + price paid) (stock option sell price chnge on day for option) LOG MAY 280 PUT 23+6 263 24 AZN MAY 2600 PUT 104+25 2548 118 THESE WILL MOVE QUICKLY!
FTSE 100 :4410.7+25 @16:36 MAIN S/R 4518 TARGET 4375/1 MINI S/R 4446 TARGET 4357/1 VOL 2850 YIELD 3.26 BAROMETER 32 LONG FTSE FUTURE (JUN 04) ARE @ 4423, 13 POINTS ABOVE CASH AND 1.5 ABOVE FAIR VALUE OF +11.5 DOW @ 10396+39 @ 17:00 (PUT YOUR SHORTS ON!!)
Register now for FREE AstraZeneca share price discussions